Evidence map›Paper›PMID 21397594›Full record

ArticleDevelopmental biology2011

Conditional expression of the TVA receptor allows clonal analysis of descendents from Cre-expressing progenitor cells.

Kevin T Beier, Maria Elena S Samson, Takahiko Matsuda, Constance L Cepko

Open access · greenAbstract read
In one paragraph

Article in Developmental biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Synthetic lethal screening in the mammalian central nervous system identifies Gpx6 as a modulator of Huntington's disease.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  18. Neuroanatomy goes viral!Frontiers in neuroanatomy · 2015
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kevin T BeierDepartment of Genetics, Department of Ophthamology, Howard Hughes Medical Institute, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
Maria Elena S Samson
Takahiko Matsuda
Constance L Cepko
Howard Hughes Medical Institute · US

Funding

MOLECULAR BIOLOGY OF RETINAL DEVELOPMENTR01EY008064 · NEI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI CEPKO, CONSTANCE L · 1989 to 2013
$4.0M
Viral tracing of genetically defined neural circuitryF31NS068012 · NINDS · HARVARD MEDICAL SCHOOL · PI BEIER, KEVIN T · 2010 to 2012
$80k
NEI NIH HHS R01 EY008064NEI NIH HHS R01EY008064NINDS NIH HHS F31 NS068012NINDS NIH HHS F31NS068012
6 · The paper itself

Abstract

An understanding of the number and types of progeny produced by progenitor cells during development provides a foundation for studies of when and where cell fate determination takes place. Lineal relationships can be revealed by the identification of descendents of cells that express a recombinase, such as Cre or Flp. This method provides data concerning gene expression history, but does not provide clonal resolution among the descendents. An alternative method employs retroviral labeling, which permits the identification of clones, but does not allow for the tracking of gene expression history. Here we report a combination of these methods to circumvent each method's limitations. By employing the specificity of Cre expression, and by selecting only a subset of cells with a Cre history for retroviral infection, clones with a gene expression history can be labeled. The method utilizes a conditional allele of the avian tumor virus receptor A (TVA), which allows infection of mouse cells following Cre activity, with mammalian retroviral vectors pseudotyped with the ASLV-A envelope glycoprotein (EnvA). We quantified the efficiency and specificity of this system in vivo and in vitro. We also generated a series of retroviral vectors encoding a variety of histochemical and fluorescent reporter genes that enable the tracking of mixtures of clones, thus enabling better resolution of clonal boundaries. This method and new vectors can be used to further our understanding of the gene expression patterns of progenitor cells that make particular daughter cells, as well as provide a platform for manipulating identified subsets of developing cells.

Indexed as

AnimalsAvian ProteinsBase SequenceCell LineageDNA PrimersEmbryonic Stem CellsGene Expression Regulation, DevelopmentalGenes, ReporterGenetic VectorsHumansIntegrasesMiceMice, TransgenicNIH 3T3 CellsReceptors, VirusRecombinant ProteinsAvian ProteinsCre recombinaseDNA PrimersIntegrasesReceptors, VirusRecombinant ProteinsTva receptor

Identifiers

PMID21397594
PMCPMC3100772
OpenAlexW2007491699

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.